À retenir
In 62 adults wearing six consumer wrist devices during a night of lab polysomnography, every device detected over 90% of sleep epochs but identified wake poorly (specificity 29.39% to 52.15%), with Cohen's kappa of 0.21 to 0.53 for stage agreement. It was one night in a sleep lab with 52 men and 10 women, so home results and women may differ.
Study design
Validation : étude/revue
Reading basis
Published abstract
Reading focus
Reference & error
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Many people read sleep stages from a smartwatch or band, but how closely those stages match laboratory sleep testing is uncertain. The authors compared six popular wrist devices against polysomnography (PSG), the gold-standard overnight sleep recording, for total sleep, wake, light, deep and REM sleep.
Population et méthode
Validation study in a sleep laboratory. Sixty-two adults (52 males and 10 females, mean age ± SD 46.0 ± 12.6 years) spent a single night with PSG while wearing two to four of the devices at once: Fitbit Charge 5, Fitbit Sense, Withings Scanwatch, Garmin Vivosmart 4, Whoop 4.0 and Apple Watch Series 8. Epoch-by-epoch sleep stages were compared with PSG, using sensitivity, specificity and Cohen's kappa. The abstract does not say how many people wore each device.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Most devices differed significantly from PSG for total sleep time, sleep efficiency, wake after sleep onset and light sleep.
- 2All devices detected more than 90% of sleep epochs (sensitivity) but specificity, the ability to recognize wake, was much lower at 29.39% to 52.15%.
- 3All wearables had a higher percentage of correctly identified epochs for deep sleep and REM sleep than for wake and light sleep.
- 4Cohen's kappa ranged from 0.21 to 0.53, fair to moderate agreement; the highest were the Apple Watch Series 8 (0.53), Fitbit Sense (0.42) and Fitbit Charge 5 (0.41).
Limites et incertitude
- 1Each person was tested for a single night in a laboratory, which may differ from sleep at home and from night to night.
- 2The sample was 52 men and 10 women, mostly middle-aged, so findings may not apply to women, older adults or people with sleep disorders.
- 3Each participant wore only two to four devices, so the devices were not all tested on the same people and cannot be ranked with certainty.
- 4This reading is based on the abstract only; the abstract does not report a per-device breakdown of errors in minutes.
Mise en perspective
These wearables are reasonably good at telling whether you are asleep and weaker at separating wake, light, deep and REM sleep, so a single night's stage breakdown should be treated as a rough estimate. The authors suggest the devices with higher kappa values could track longer-term changes in sleep architecture. They cannot diagnose a sleep disorder.
Vos données
Use the same device and wear it the same way every night, then watch the trend in total sleep and consistency over weeks, not one night's deep or REM numbers. Compare only with your own earlier data, since different brands score stages differently.
Comprendre ce type de preuve
Agreement is specific to the device, firmware, reference, population and setting. Correlation is not agreement, and validating a metric is not proof of diagnostic or treatment benefit.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Study objectives
The aim of this study is to assess the performance of six different consumer wearable sleep-tracking devices, namely the Fitbit Charge 5, Fitbit Sense, Withings Scanwatch, Garmin Vivosmart 4, Whoop 4.0, and the Apple Watch Series 8, for detecting sleep parameters compared to the gold standard, polysomnography (PSG).
Methods
Sixty-two adults (52 males and 10 females, mean age ± SD = 46.0 ± 12.6 years) spent a single night in the sleep laboratory with PSG while simultaneously using two to four wearable devices.
Results
The results indicate that most wearables displayed significant differences with PSG for total sleep time, sleep efficiency, wake after sleep onset, and light sleep (LS). Nevertheless, all wearables demonstrated a higher percentage of correctly identified epochs for deep sleep and rapid eye movement sleep compared to wake (W) and LS. All devices detected >90% of sleep epochs (ie, sensitivity), but showed lower specificity (29.39%-52.15%). The Cohen's kappa coefficients of the wearable devices ranged from 0.21 to 0.53, indicating fair to moderate agreement with PSG.
Conclusions
Our results indicate that all devices can benefit from further improvement for multistate categorization. However, the devices with higher Cohen's kappa coefficients, such as the Fitbit Sense (κ = 0.42), Fitbit Charge 5 (κ = 0.41), and Apple Watch Series 8 (κ = 0.53), could be effectively used to track prolonged and significant changes in sleep architecture.
Sources et attribution
A performance validation of six commercial wrist-worn wearable sleep-tracking devices for sleep stage scoring compared to polysomnography.
Schyvens AM, Peters B, Van Oost NC, Aerts JM, Masci F, Neven A, Dirix H, Wets G, Ross V, Verbraecken J.
Sleep advances : a journal of the Sleep Research Society · 2025-03-22
DOI: 10.1093/sleepadvances/zpaf021 ↗PubMed · 40303381 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Exercise improved sleep-quality scores in adults 45 and older with sleep disorders
Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.
Journal of Exercise Science & Fitness
Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults
Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.
Sleep
Sleep extension cut daily energy intake by about 270 kcal in adults with overweight
In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.
JAMA Internal Medicine
Six hours or less of sleep at 50 and 60 linked to higher dementia risk
In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.
Nature Communications

